Potter syndrome dominant type
Potter Syndrome Dominant Type is a rare genetic disorder characterized by a variety of physical abnormalities. The syndrome is named after Edith Potter, a pathologist who first described the condition in 1946.
Overview[edit | edit source]
Potter Syndrome Dominant Type is a subtype of Potter Syndrome, a group of disorders that affect the development of the kidneys and urinary tract. The dominant type is inherited in an Autosomal dominant manner, meaning that an affected individual has a 50% chance of passing the disorder to each of their children.
Symptoms[edit | edit source]
The symptoms of Potter Syndrome Dominant Type can vary widely between individuals. Common symptoms include Pulmonary hypoplasia (underdeveloped lungs), Oligohydramnios (low amniotic fluid), and Renal agenesis (absence of one or both kidneys). Other possible symptoms include Facial abnormalities, Limb abnormalities, and Eye abnormalities.
Diagnosis[edit | edit source]
Diagnosis of Potter Syndrome Dominant Type is typically made through a combination of Genetic testing, Ultrasound imaging, and clinical examination. Genetic testing can identify mutations in the genes associated with the disorder, while ultrasound imaging can reveal physical abnormalities in the kidneys and urinary tract.
Treatment[edit | edit source]
There is currently no cure for Potter Syndrome Dominant Type. Treatment is supportive and aims to manage symptoms and improve quality of life. This may include Dialysis or Kidney transplantation for individuals with kidney failure, and Respiratory therapy for those with lung problems.
Prognosis[edit | edit source]
The prognosis for individuals with Potter Syndrome Dominant Type can vary depending on the severity of symptoms. Some individuals may live into adulthood with appropriate management, while others may experience life-threatening complications in infancy or early childhood.
See Also[edit | edit source]
NIH genetic and rare disease info[edit source]
Potter syndrome dominant type is a rare disease.
| Potter syndrome dominant type Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
